Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1588147866;47867;47868 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
N2AB1424042943;42944;42945 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
N2A1331340162;40163;40164 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
N2B681620671;20672;20673 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
Novex-1694121046;21047;21048 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
Novex-2700821247;21248;21249 chr2:178617444;178617443;178617442chr2:179482171;179482170;179482169
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-3
  • Domain position: 23
  • Structural Position: 25
  • Q(SASA): 0.2391
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs1437852479 None 0.999 N 0.567 0.425 0.29527378943 gnomAD-3.1.2 6.59E-06 None None None None I None 2.42E-05 0 0 0 0 None 0 0 0 0 0
E/K rs1437852479 None 0.999 N 0.567 0.425 0.29527378943 gnomAD-4.0.0 6.58718E-06 None None None None I None 2.41815E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2328 likely_benign 0.2618 benign -0.815 Destabilizing 0.999 D 0.713 prob.delet. N 0.479721929 None None I
E/C 0.866 likely_pathogenic 0.8841 pathogenic -0.566 Destabilizing 1.0 D 0.836 deleterious None None None None I
E/D 0.1701 likely_benign 0.2168 benign -1.005 Destabilizing 0.999 D 0.463 neutral N 0.483932486 None None I
E/F 0.786 likely_pathogenic 0.8181 pathogenic -0.219 Destabilizing 1.0 D 0.82 deleterious None None None None I
E/G 0.2234 likely_benign 0.2555 benign -1.16 Destabilizing 1.0 D 0.747 deleterious N 0.471705947 None None I
E/H 0.5913 likely_pathogenic 0.6429 pathogenic -0.387 Destabilizing 1.0 D 0.699 prob.neutral None None None None I
E/I 0.4289 ambiguous 0.4738 ambiguous 0.125 Stabilizing 1.0 D 0.832 deleterious None None None None I
E/K 0.2509 likely_benign 0.2928 benign -0.772 Destabilizing 0.999 D 0.567 neutral N 0.474175948 None None I
E/L 0.4316 ambiguous 0.5006 ambiguous 0.125 Stabilizing 1.0 D 0.805 deleterious None None None None I
E/M 0.4805 ambiguous 0.519 ambiguous 0.427 Stabilizing 1.0 D 0.801 deleterious None None None None I
E/N 0.2945 likely_benign 0.3707 ambiguous -1.17 Destabilizing 1.0 D 0.706 prob.neutral None None None None I
E/P 0.9706 likely_pathogenic 0.9693 pathogenic -0.167 Destabilizing 1.0 D 0.803 deleterious None None None None I
E/Q 0.1826 likely_benign 0.1958 benign -1.029 Destabilizing 1.0 D 0.621 neutral N 0.483932486 None None I
E/R 0.4362 ambiguous 0.4555 ambiguous -0.387 Destabilizing 1.0 D 0.704 prob.neutral None None None None I
E/S 0.2632 likely_benign 0.302 benign -1.458 Destabilizing 0.999 D 0.636 neutral None None None None I
E/T 0.2974 likely_benign 0.3262 benign -1.18 Destabilizing 1.0 D 0.779 deleterious None None None None I
E/V 0.2885 likely_benign 0.3133 benign -0.167 Destabilizing 1.0 D 0.783 deleterious N 0.479646859 None None I
E/W 0.9342 likely_pathogenic 0.9408 pathogenic 0.017 Stabilizing 1.0 D 0.837 deleterious None None None None I
E/Y 0.6863 likely_pathogenic 0.7288 pathogenic 0.001 Stabilizing 1.0 D 0.814 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.